Home » 臨床試驗 » 糖尿病

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes

Status: This study is currently recruiting participants
First Received: August 5, 2011
Information provided by: Shandong University
Sponsors and Collaborators: Shandong University
Contacts: chengyun zheng, Ph. D +86-531-85875635 chengyun.zheng@ki.se kdx2002@126.com

Stem Cells Infusion With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

Status: This study is ongoing, but not recruiting participants.
First Received: October 6, 2008
Information provided by: Fuzhou General Hospital
Sponsors and Collaborators: Fuzhou General Hospital
Contacts: none

Effect of Thiazolidinediones on Human Bone

Status: Recruiting
First Received: June 24, 2009
Information provided by: Emory University
Sponsors and Collaborators: Emory University
Contacts: Natasha B khazai, M.D. ☎ 404-778-1678  ➔ nkhazai@emory.edu Guillermo umpierrez, M.D. ☎ 404-778-1665  ➔ geumpie@emory.edu

Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients

Status: Recruiting
First Received: December 7, 2010
Information provided by: University of Sao Paulo
Sponsors and Collaborators: University of Sao Paulo
Contacts: Julio Voltarelli, MD, PhD ☎+55 16 2101 9369 ➔ jcvoltar@fmrp.usp.br Carlos E Couri ☎+5516 91495151 ➔ ce.couri@yahoo.com.br

Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus

Status: Active, not recruiting
First Received: October 12, 2010
Information provided by: Qingdao University
Sponsors and Collaborators: Qingdao University
Contacts: /

Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells

Status: Not yet recruiting
First Received: February 16, 2010
Information provided by: Uppsala University Hospital
Sponsors and Collaborators: Uppsala University Hospital
Contacts: Per-Ola Carlsson, MD, PhD ☎ +46 18 471 4425 ➔ Per-Ola.Carlsson@mcb.uu.se Olle Korsgren, MD, PhD ☎ +46 18 6114187 ➔ Olle.Korsgren@klinimm.uu.se

Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes

Status: Not yet recruiting
First Received: February 16, 2010
Information provided by: Uppsala University Hospital
Sponsors and Collaborators: Uppsala University Hospital
Contacts: Per-Ola Carlsson, MD, PhD ☎ +46 18 471 4425 ➔ Per-Ola.Carlsson@mcb.uu.se Olle Korsgren, MD, PhD ☎ +46 18 6114187 ➔ Olle.Korsgren@klinimm.uu.se

PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

Status: Active, not recruiting
First Received: June 2, 2008
Information provided by: Osiris Therapeutics
Sponsors and Collaborators: Osiris Therapeutics
Contacts: /

Autologous Mesenchymal Stem Cell and Bone Marrow Stem Cell Infusion Combined With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

Status: Recruiting
First Received: October 6, 2008
Information provided by: Fuzhou General Hospital
Sponsors and Collaborators: Fuzhou General Hospital
Contacts: Jianming Tan, Professor ☎ 008613375918000 ➔ doctortjm@yahoo.com

Stem Cell Therapy for Type 2 Diabetes Mellitus

Status: Not yet recruiting
First Received: June 10, 2010
Information provided by: Cellonis Biotechnology Co. Ltd.
Sponsors and Collaborators: Cellonis Biotechnology Co. Ltd.
Contacts: /

Stem Cell Therapy for Type 1 Diabetes Mellitus

Status: Not yet recruiting
First Received: June 10, 2010
Information provided by: Cellonis Biotechnology Co. Ltd.
Sponsors and Collaborators: Cellonis Biotechnology Co. Ltd.
Contacts: /

Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia (CeTMAd/ICPD200)

Status: Recruiting
First Received: June 10, 2010
Information provided by: Fundacion Progreso y Salud, Spain
Sponsors and Collaborators: Fundacion Progreso y Salud, Spain
Contacts: Carlos III Health Institute Ana Cardesa

Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia (CeTMAd/ICPD200)

Status: Recruiting
First Received: June 10, 2010
Information provided by: Fundacion Progreso y Salud, Spain
Sponsors and Collaborators: Fundacion Progreso y Salud, Spain
Contacts: Carlos III Health Institute Ana Cardesa ☎ 0034 955 01 9040

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia in Diabetic Patients

Status: Recruiting dacion
First Received: March 25, 2008
Information provided by: Fundacion Progreso y Salud, Spain
Sponsors and Collaborators: Progreso y Salud, Spain
Contacts: Carlos III Health Institute Inmaculada C Perez-Camacho, MD, PhD ☎ +34955693440 ➔ Ipercam06@gmail.com
Rafael J Ruiz-Salmerón, MD, PhD ☎ +34955693440 ➔ rjruizsalmeron@yahoo.es

Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients

Status: Recruiting
First Received: March 25, 2008
Information provided by: Fuzhou General Hospital
Sponsors and Collaborators: Fuzhou General Hospital
Contacts: Jianming Tan, Professor ☎ 008613375918000 ➔ tanjm156@yahoo.com.cn

Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia

Status: Completed
First Received: February 8, 2010
Information provided by: Ruhr University of Bochum
Sponsors and Collaborators: Ruhr University of Bochum
Contacts: /

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot

Status: Not yet recruiting
First Received: October 6, 2010
Information provided by: Qingdao University
Sponsors and Collaborators: Qingdao University
Contacts: Jianxia Hu, MD ☎ 86-0532-82911676 ➔ qdyxyhjx@126.com
Hong Gao, MS ☎ 86-0532-82911676 ➔ honggaogloria@gmail.com

Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer

Status: Completed
First Received: August 4, 2009
Information provided by: Third Military Medical University
Sponsors and Collaborators: Third Military Medical University
Contacts: /

The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers

Status: Not yet recruiting
First Received: December 24, 2008
Information provided by: Washington D.C. Veterans Affairs Medical Center
Sponsors and Collaborators: Washington D.C. Veterans Affairs Medical Center
Contacts: /

Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus

Status: This study is ongoing, but not recruiting participants.
First Received: June 15, 2011
Information provided by: Fuzhou General Hospital
Sponsors and Collaborators: Fuzhou General Hospital
Contacts: /

Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

Status: This study is not yet open for participant recruitment.
First Received: December 18, 2011
Information provided by: S-Evans Biosciences Co.,Ltd.
Sponsors and Collaborators:
  • S-Evans Biosciences Co.,Ltd.
  • the First Affiliated Hospital of Zhejiang University
  • the First Affiliated Hospital of WenZhou Medical College
  • Zhenjiang First People’s Hospital
Contacts: Charlie Xiang, Professor 86-571-87236436 cxiang@zju.edu.cn

免費訂閱最新資訊

只需輸入閣下之電郵地址,我們便會向定時你發送本站最新新聞及相關資訊,費用全免。

聯絡我們

Name*

Email*

Tel

Message*

captcha

*require